Use of 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas

Details for Australian Patent Application No. 2007282027 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007282027

PCT Pub. Number WO2008/019065

Priority 60/835,752 03.08.06 US

Filing date 2 August 2007

Wipo publication date 14 February 2008

Acceptance publication date 2 August 2012

International Classifications

A61K 31/454

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 Antineoplastic agents

Event Publications

19 March 2009 PCT application entered the National Phase

  PCT publication WO2008/019065 Priority application(s): WO2008/019065

2 August 2012 Application Accepted

  Published as AU-B-2007282027

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007282033

2007282025-Defoliant composition and method